- Home
- LPRO vs BHST Comparison
LPRO vs BHST Comparison
Compare LPRO & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPRO
- BHST
- Stock Information
- Founded
- LPRO 2000
- BHST 2007
- Country
- LPRO United States
- BHST Canada
- Employees
- LPRO N/A
- BHST N/A
- Industry
- LPRO Finance: Consumer Services
- BHST
- Sector
- LPRO Finance
- BHST
- Exchange
- LPRO Nasdaq
- BHST Nasdaq
- Market Cap
- LPRO 124.6M
- BHST 106.0M
- IPO Year
- LPRO N/A
- BHST N/A
- Fundamental
- Price
- LPRO $1.84
- BHST $6.47
- Analyst Decision
- LPRO Buy
- BHST Strong Buy
- Analyst Count
- LPRO 8
- BHST 2
- Target Price
- LPRO $4.14
- BHST $13.00
- AVG Volume (30 Days)
- LPRO 4.0M
- BHST 45.4K
- Earning Date
- LPRO 05-07-2025
- BHST 05-15-2025
- Dividend Yield
- LPRO N/A
- BHST N/A
- EPS Growth
- LPRO N/A
- BHST N/A
- EPS
- LPRO N/A
- BHST N/A
- Revenue
- LPRO $17,672,000.00
- BHST $25,188,000.00
- Revenue This Year
- LPRO $320.95
- BHST $116.40
- Revenue Next Year
- LPRO $6.76
- BHST $55.91
- P/E Ratio
- LPRO N/A
- BHST N/A
- Revenue Growth
- LPRO N/A
- BHST 98.77
- 52 Week Low
- LPRO $0.70
- BHST $0.00
- 52 Week High
- LPRO $6.97
- BHST $7.38
- Technical
- Relative Strength Index (RSI)
- LPRO 58.17
- BHST N/A
- Support Level
- LPRO $1.24
- BHST N/A
- Resistance Level
- LPRO $1.42
- BHST N/A
- Average True Range (ATR)
- LPRO 0.17
- BHST 0.00
- MACD
- LPRO 0.18
- BHST 0.00
- Stochastic Oscillator
- LPRO 96.26
- BHST 0.00
About LPRO Open Lending Corporation
Open Lending Corp is engaged in providing automated lending services to financial institutions. The company offers loan analytics, risk-based pricing, risk modeling, and automated decision technology. Its Lenders Protection Program ("LPP") enables automotive lenders to make loans that are largely insured against, losses from defaults.
About BHST BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.